Literature DB >> 9685870

Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method.

M F Zambaux1, F Bonneaux, R Gref, P Maincent, E Dellacherie, M J Alonso, P Labrude, C Vigneron.   

Abstract

Nanoparticles were prepared by the double emulsion method (w/o/w), using methylene chloride as an organic solvent and polyvinyl alcohol (PVA) or human serum albumin (HSA) as a surfactant. Experimental parameters such as the preparation temperature, the solvent evaporation methods, the internal aqueous phase volume, the surfactant concentration and the polymer molecular weight were investigated for particle size, the zeta potential, the residual surfactant percentage and the polydispersity index. Preparation parameters leading to particles with well-defined characteristics such as an average size around 200 nm and a polydispersity index lower than 0.1 were identified. The conditions were optimized to ensure protein encapsulation: a cool temperature, a short processing time, a sufficient internal aqueous phase and careful washing. It appeared that the higher the surfactant concentration in the external aqueous phase was, the smaller the particles, the lower the polydispersity index and the higher the residual amount of surfactant were. For PVA or HSA, the agreement between the convenient surfactant concentration and its critical aggregation concentration could be emphasized. Otherwise, an increased polymer molecular weight led both to a slightly decreased particle size and to a lower polydispersity index. Moreover, multilayer absorption of PVA which does not depend on Poly(lactic-acid) molecular weight was exhibited. Finally, the zeta potential resulted from the polymer molecular weight and the residual PVA.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9685870     DOI: 10.1016/s0168-3659(97)00106-5

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  58 in total

Review 1.  Drug transport to brain with targeted nanoparticles.

Authors:  Jean-Christophe Olivier
Journal:  NeuroRx       Date:  2005-01

2.  Functional TNFα gene silencing mediated by polyethyleneimine/TNFα siRNA nanocomplexes in inflamed colon.

Authors:  Hamed Laroui; Arianne L Theiss; Yutao Yan; Guillaume Dalmasso; Hang T T Nguyen; Shanthi V Sitaraman; Didier Merlin
Journal:  Biomaterials       Date:  2011-02       Impact factor: 12.479

Review 3.  Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers.

Authors:  Julie A Champion; Yogesh K Katare; Samir Mitragotri
Journal:  J Control Release       Date:  2007-04-11       Impact factor: 9.776

Review 4.  Methods for the preparation and manufacture of polymeric nanoparticles.

Authors:  Christine Vauthier; Kawthar Bouchemal
Journal:  Pharm Res       Date:  2008-12-24       Impact factor: 4.200

5.  Nanoparticles of esterified polymalic acid for controlled anticancer drug release.

Authors:  Alberto Lanz-Landázuri; José Portilla-Arias; Antxon Martínez de Ilarduya; Montserrat García-Alvarez; Eggehard Holler; Julia Ljubimova; Sebastián Muñoz-Guerra
Journal:  Macromol Biosci       Date:  2014-06-06       Impact factor: 4.979

Review 6.  Promises of Nanotherapeutics in Obesity.

Authors:  Garrett I Ash; Dongin Kim; Mahua Choudhury
Journal:  Trends Endocrinol Metab       Date:  2019-05-21       Impact factor: 12.015

7.  Preparation of particulate polymeric therapeutics for medical applications.

Authors:  Jia Zhuang; Ronnie H Fang; Liangfang Zhang
Journal:  Small Methods       Date:  2017-07-25

8.  Loading of tetanus toxoid to biodegradable nanoparticles from branched poly(sulfobutyl-polyvinyl alcohol)-g-(lactide-co-glycolide) nanoparticles by protein adsorption: a mechanistic study.

Authors:  Tobias Jung; Walter Kamm; Armin Breitenbach; Gerhard Klebe; Thomas Kissel
Journal:  Pharm Res       Date:  2002-08       Impact factor: 4.200

9.  PLGA/TPGS nanoparticles for controlled release of paclitaxel: effects of the emulsifier and drug loading ratio.

Authors:  Li Mu; Si-Shen Feng
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

10.  Nanomedicine for uterine leiomyoma therapy.

Authors:  Hazem Ali; Gokhan Kilic; Kathleen Vincent; Massoud Motamedi; Erik Rytting
Journal:  Ther Deliv       Date:  2013-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.